COVID-19

New data suggest that respiratory syncytial virus may be returning to its pre-COVID-19 seasonality — a winter peak — which could help determine when people should be vaccinated against it, researchers said.

Registry data revealed large decreases in the utilization of PCI during the COVID‐19 pandemic, which rebounded quickly by mid-2021.

Older adults with a history of hypothyroidism who were hospitalized with COVID-19 had a similar risk for severe outcomes and mortality compared with those without hypothyroidism, according to study data.

May 11 will mark the end of the 3-year COVID-19 national public health emergency, as announced earlier this year by President Joe Biden and HHS.

Medicare beneficiaries using telehealth services for opioid use disorder during the COVID-19 pandemic had a 33% lower risk for fatal drug overdose compared with beneficiaries receiving no treatment, findings in JAMA Psychiatry showed.

The percentage of people receiving prescription stimulants rose from 2016 to 2021, including large increases during the first year of the COVID-19 pandemic, particularly among adolescent girls and adult men and women, data show.

Treatment with a monoclonal antibody within 2 days of a COVID-19 diagnosis reduced the risk for hospitalization or death by almost 40%, according to a study that assessed patient outcomes over a nearly 2-year period.

The FDA has granted an emergency use authorization for the monoclonal antibody vilobelimab in the treatment of patients with COVID-19 who have undergone ventilation or are on life support, according to a press release from the agency.

A high risk for in-hospital mortality, ICU admittance and mechanical ventilation was found in patients with COVID-19 plus a community-acquired bacterial infection, according to study results published in Critical Care.

Children who were diagnosed with type 1 diabetes had differences in their gut microbiome at age 1 year from those without diabetes, according to recent data.